Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 145,369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Anemia, Sickle Cell
Interventions: GBT440; Drug
Lead sponsor: Global Blood Therapeutics; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Brain and Central Nervous System Tumors
Interventions: transferrin-CRM107; Biological
Lead sponsor: Xenova Biomedix; Industry
Eligibility: 5 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 2
States / cities: Orange, California • Charleston, South Carolina

Conditions: Defect of Articular Cartilage, Osteochondritis Dissecans
Interventions: Microfracture, Cartilage Autograft Implantation System; Procedure · Device
Lead sponsor: DePuy Mitek; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 27
States / cities: Tucson, Arizona • Bentonville, Arkansas • Encinitas, California + 24 more

Conditions: Cancer
Interventions: ziv-aflibercept; Biological
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 2
States / cities: New York, New York • Nashville, Tennessee

Conditions: Colon Adenocarcinoma
Interventions: Carbon C 14 Oxaliplatin, Oxaliplatin; Drug
Lead sponsor: Edward Kim; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Acute Appendicitis, Abscess
Interventions: Normal Saline, Sterile Water; Procedure
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 6 Years and older
Enrollment: 241 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Dysphagia
Interventions: Isometric Progressive Resistance Oropharyngeal Therapy; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years to 95 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 9
States / cities: Evanston, Illinois • Lexington, Kentucky • Minneapolis, Minnesota + 5 more

Conditions: Lewy Body Dementia (LBD), Alzheimer Dementia (AD)
Interventions: C-11 ER-176, Blood Test; Drug · Diagnostic Test
Lead sponsor: Val Lowe; Other
Eligibility: 60 Years and older
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Post-Traumatic Stress Disorder, Brain Injuries, Traumatic
Interventions: Not listed
Lead sponsor: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction, Sexuality and Reproductive Issues
Interventions: sildenafil citrate, Placebo; Drug · Other
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 30
States / cities: Concord, California • Inglewood, California • Walnut Creek, California + 23 more

Conditions: Alzheimer Disease
Interventions: [123I]AV94; Drug
Lead sponsor: Institute for Neurodegenerative Disorders; Other
Eligibility: 50 Years and older
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Myopia
Interventions: Control Contact Lens (stenfilcon A), Test Contact Lens (senofilcon A); Device
Lead sponsor: CooperVision, Inc.; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 3
States / cities: Ocoee, Florida • Vestal, New York • Granville, Ohio

Conditions: Anxiety
Interventions: Anxiety Risk Reduction; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Arthritis, Rheumatoid
Interventions: Placebo + methotrexate (MTX) (Group 1), Ustekinumab + MTX (Group 2), Ustekinumab + MTX (Group 3), CNTO 1959 + MTX (Group 4), CNTO 1959 + MTX (Group 5); Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Palm Harbor, Florida • Rock Island, Illinois • St Louis, Missouri

Conditions: Migraine Disorders
Interventions: onabotulinumtoxinA, Topiramate; Biological · Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 32
States / cities: Phoenix, Arizona • Encinitas, California • Fresno, California + 28 more

Conditions: Pancreatic Cancer
Interventions: Cyclophosphamide, Nivolumab, GVAX Pancreas Vaccine, Stereotactic Body Radiation (SBRT); Drug · Radiation
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland • Milwaukee, Wisconsin

Conditions: Breast Cancer, Breast Neoplasms, Breast Carcinoma, Breast Cancer Female
Interventions: Breast Cancer Survivor Education Program; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 22 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Myeloma
Interventions: P-BCMA-ALLO1 CAR-T cells, Rimiducid, Methotrexate; Biological · Drug
Lead sponsor: Poseida Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2042
U.S. locations: 23
States / cities: Goodyear, Arizona • San Diego, California • San Francisco, California + 19 more

Conditions: Herpes Labialis, HSV
Interventions: Squaric Acid Dibutyl Ester; Drug
Lead sponsor: Squarex, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Doral, Florida • Saint Paul, Minnesota

Conditions: Type 1 Diabetes
Interventions: interoperable Artificial Pancreas System (iAPS), Sensor-Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS); Device · Other
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 5
States / cities: Santa Barbara, California • Stanford, California • Boston, Massachusetts + 2 more

Conditions: Postpartum Depression, Infant Development, Rhythm; Sleep
Interventions: Resources for Postpartum Parenting; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Glaucoma, Open-Angle
Interventions: Standard Automatic Perimetry Humphrey Field Analyzer, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT); Diagnostic Test
Lead sponsor: Wills Eye; Other
Eligibility: 20 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Migraine, Obesity
Interventions: Behavioral Weight Loss Intervention, Migraine Education; Behavioral · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Muscle Atrophy, Physical Deconditioning
Interventions: RENEW; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 65 Years to 95 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma

Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy

Water And Saline Head-to-head In The Blinded Evaluation Study Trial

Study of Tongue Strengthening for Swallowing Problems

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD)

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

Cognitive Anxiety Sensitivity Treatment for Suicide

A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy

Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Breast Cancer Survivor Educational Intervention

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

Social Circumstances, Parenting Techniques, and Infant Development

Evaluating Home Testing Devices for the Management of Glaucoma

Behavioral Weight Loss as a Treatment for Migraine in Obese Women

Reducing Falls With RENEW in Older Adults Who Have Fallen